Yourlocation: Home > News > Clinical pregnancy women disabled chenodeoxycholic acid
Deoxycholic acid:
Chenodeoxycholic acid, due to its potential liver toxicity, it is disabled.
② Through animal studies found that early pregnancy using ursodeoxycholic acid will have embryo toxicity. There is also a lack of experimental data for the first three months of pregnancy. Women of childbearing age can only use ursodeoxycholic acid capsules after taking safe contraceptive measures. Before starting treatment, the patient should be excluded from pregnancy. For the sake of safety, ursodeoxycholic acid capsules can not be taken in the first three months of gestation.
Although there is no data that ursodeoxycholic acid can enter the breast milk, but it is recommended in breastfeeding do not take ursodeoxycholic acid capsules.
Angiotensin-converting enzyme inhibitor (ACEI):
Pregnant women taking ACE inhibitors will likely cause fetal or neonatal disease or death. There are dozens of such reports in the world's literature.
Aminopterin + methotrexate:
Aminopterin is a folic acid antagonist, structurally similar to methotrexate.
Methotrexate is a folic acid antagonist that can cause abortion in the fetus. Three months before pregnancy can cause deformity, abnormal reports include (pointed deformity), chevron and coronal seam missing, eye distance is too wide, skin defects.

Address:A3 Building, Dongli Aviation Business District,No.8,Pingying Road, Dongli District, Tianjin, P.R.China, 300300 Tel:+86-022-58602231 Fax:+86-022-58602232
Copyright © Tianjin NWS Biotechnology and Medicine Co. Ltd.